A

Avalyn Pharma Inc.

21 employees

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Medical

Pharmaceutical

Biopharma

Date founded

2011

Funding rounds raised

Total raised

$175M

from 16 investors over 16 rounds

A

Avalyn Pharma Inc. raised $175M on September 27, 2023

Investors: Surveyor Capital, Vida Ventures, LLC, Novo Holdings, S.R. One Ltd, Wellington Management, RiverVest Venture Partners and Perceptive Advisors

A

Avalyn Pharma Inc. raised $36M on April 27, 2020

Investors: RiverVest Venture Partners, Norwest Venture Partners, Novo Holdings and F-Prime Capital Partners

A

Avalyn Pharma Inc. raised $62M on January 1, 2017

Investors: RiverVest Venture Partners, F-Prime Capital Partners, Edmond de Rothschild, Andera Partners and Novo Holdings